Novartis operates businesses with global scale and strong customer ties, focusing on innovative patented medicines, generics and eye care devices. The Innovative Medicines Division has two business units: Novartis Pharmaceuticals commercializes innovative, patented primary care and specialty medicines to enhance health outcomes for patients and health-care providers. Novartis Oncology commercializes a portfolio of patented oncology, hematology and rare disease medicines to address the medical needs of people with cancer and related diseases.